These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 14633622)

  • 1. Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma.
    Tsuchiya A; Sakamoto M; Yasuda J; Chuma M; Ohta T; Ohki M; Yasugi T; Taketani Y; Hirohashi S
    Am J Pathol; 2003 Dec; 163(6):2503-12. PubMed ID: 14633622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific expression of hepatocyte nuclear factor-1beta in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis.
    Higashiguchi A; Yamada T; Susumu N; Mori T; Suzuki A; Aoki D; Sakamoto M
    Cancer Sci; 2007 Mar; 98(3):387-91. PubMed ID: 17270029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic Significance of HNF-1β, AIRD1A, and PIK3CA Expression in Ovarian Clear Cell Carcinoma: A Tissue Microarray Study of 130 Cases.
    Ye S; Yang J; You Y; Cao D; Huang H; Wu M; Chen J; Lang J; Shen K
    Medicine (Baltimore); 2016 Mar; 95(9):e3003. PubMed ID: 26945423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.
    Xiao W; Awadallah A; Xin W
    Int J Clin Exp Pathol; 2012; 5(7):642-50. PubMed ID: 22977660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of osteopontin in clear cell carcinoma of the ovary: close association with HNF-1beta expression.
    Kato N; Motoyama T
    Histopathology; 2008 May; 52(6):682-8. PubMed ID: 18393978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomethylation of hepatocyte nuclear factor-1beta (HNF-1beta) CpG island in clear cell carcinoma of the ovary.
    Kato N; Tamura G; Motoyama T
    Virchows Arch; 2008 Feb; 452(2):175-80. PubMed ID: 18066692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemistry for hepatocyte nuclear factor-1beta (HNF-1beta): a marker for ovarian clear cell carcinoma.
    Kato N; Toukairin M; Asanuma I; Motoyama T
    Diagn Cytopathol; 2007 Apr; 35(4):193-7. PubMed ID: 17351940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology of clear cell carcinoma of the ovary: A basic view based on cultured cells and modern view from comprehensive approaches.
    Kato N
    Pathol Int; 2020 Sep; 70(9):591-601. PubMed ID: 32476214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annexin IV is differentially expressed in clear cell carcinoma of the ovary.
    Miao Y; Cai B; Liu L; Yang Y; Wan X
    Int J Gynecol Cancer; 2009 Dec; 19(9):1545-9. PubMed ID: 19955935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary.
    Kato N; Sasou S; Motoyama T
    Mod Pathol; 2006 Jan; 19(1):83-9. PubMed ID: 16258507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.
    Huang W; Cheng X; Ji J; Zhang J; Li Q
    Int J Gynecol Pathol; 2016 Jan; 35(1):66-71. PubMed ID: 26166716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of hepatocyte nuclear factor-1beta in the pathogenesis of clear cell carcinoma of the ovary.
    Kobayashi H; Yamada Y; Kanayama S; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sakata M; Sado T; Oi H
    Int J Gynecol Cancer; 2009 Apr; 19(3):471-9. PubMed ID: 19407577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theoretical model of treatment strategies for clear cell carcinoma of the ovary: focus on perspectives.
    Yoshida S; Furukawa N; Haruta S; Tanase Y; Kanayama S; Noguchi T; Sakata M; Yamada Y; Oi H; Kobayashi H
    Cancer Treat Rev; 2009 Nov; 35(7):608-15. PubMed ID: 19665848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic determinants of ovarian clear cell carcinoma biology.
    Yamaguchi K; Huang Z; Matsumura N; Mandai M; Okamoto T; Baba T; Konishi I; Berchuck A; Murphy SK
    Int J Cancer; 2014 Aug; 135(3):585-97. PubMed ID: 24382740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of alpha-methylacyl-CoA racemase in vaginal gastric-type adenocarcinoma and uterine clear cell carcinoma.
    Hu J; Lu Y; Tang N; Li L; Guo P; Zhang Y
    Indian J Pathol Microbiol; 2020; 63(1):49-52. PubMed ID: 32031122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional upregulation of HNF-1β by NF-κB in ovarian clear cell carcinoma modulates susceptibility to apoptosis through alteration in bcl-2 expression.
    Suzuki E; Kajita S; Takahashi H; Matsumoto T; Tsuruta T; Saegusa M
    Lab Invest; 2015 Aug; 95(8):962-72. PubMed ID: 26030369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary.
    Itamochi H; Oumi N; Oishi T; Shoji T; Fujiwara H; Sugiyama T; Suzuki M; Kigawa J; Harada T
    Int J Clin Oncol; 2015 Oct; 20(5):967-73. PubMed ID: 25744580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte Nuclear Factor-1β Expression in Clear Cell Renal Cell Carcinoma and Urothelial Carcinoma With Clear Cell Features: A Potential Diagnostic Pitfall.
    Hanley KZ; Cohen C; Osunkoya AO
    Appl Immunohistochem Mol Morphol; 2017 Feb; 25(2):134-138. PubMed ID: 26574638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HNF-1β in ovarian carcinomas with serous and clear cell change.
    DeLair D; Han G; Irving JA; Leung S; Ewanowich CA; Longacre TA; Gilks CB; Soslow RA
    Int J Gynecol Pathol; 2013 Nov; 32(6):541-6. PubMed ID: 24071869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation.
    Wiegand KC; Hennessy BT; Leung S; Wang Y; Ju Z; McGahren M; Kalloger SE; Finlayson S; Stemke-Hale K; Lu Y; Zhang F; Anglesio MS; Gilks B; Mills GB; Huntsman DG; Carey MS
    BMC Cancer; 2014 Feb; 14():120. PubMed ID: 24559118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.